Rumex vesicarius L. boosts the effectiveness of sorafenib in triple-negative breast cancer by downregulating BCl2, mTOR, and JNK, and upregulating p21 expression
Article in Pathology - Research and Practice (September 2023)
The most recent citing publications are shown below. View all 6 publications that cite this research output on Dimensions.
Article in Pathology - Research and Practice (September 2023)
Book chapter (August 2023)
Article in Veterinary Sciences (June 2023)